These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 15766857

  • 21. Prospective trial of voice outcomes after thyroidectomy: evaluation of patient-reported and clinician-determined voice assessments in identifying postthyroidectomy dysphonia.
    Stojadinovic A, Henry LR, Howard RS, Gurevich-Uvena J, Makashay MJ, Coppit GL, Shriver CD, Solomon NP.
    Surgery; 2008 Jun; 143(6):732-42. PubMed ID: 18549889
    [Abstract] [Full Text] [Related]

  • 22. Acoustic measures of symptoms in abductor spasmodic dysphonia.
    Edgar JD, Sapienza CM, Bidus K, Ludlow CL.
    J Voice; 2001 Sep; 15(3):362-72. PubMed ID: 11575633
    [Abstract] [Full Text] [Related]

  • 23. Electromyographic assessment of spasmodic dysphonia patients prior to botulinum toxin injection.
    Rodriquez AA, Ford CN, Bless DM, Harmon RL.
    Electromyogr Clin Neurophysiol; 1994 Sep; 34(7):403-7. PubMed ID: 7859668
    [Abstract] [Full Text] [Related]

  • 24. Longitudinal follow-up of adductor spasmodic dysphonia patients after botulinum toxin injection: quality of life results.
    Paniello RC, Barlow J, Serna JS.
    Laryngoscope; 2008 Mar; 118(3):564-8. PubMed ID: 18216744
    [Abstract] [Full Text] [Related]

  • 25. Effects of voicing and syntactic complexity on sign expression in adductor spasmodic dysphonia.
    Erickson ML.
    Am J Speech Lang Pathol; 2003 Nov; 12(4):416-24. PubMed ID: 14658993
    [Abstract] [Full Text] [Related]

  • 26. Identification of symptoms for spasmodic dysphonia and vocal tremor: a comparison of expert and nonexpert judges.
    Barkmeier JM, Case JL, Ludlow CL.
    J Commun Disord; 2001 Nov; 34(1-2):21-37. PubMed ID: 11322567
    [Abstract] [Full Text] [Related]

  • 27. [The smokers voice self assessment based on Voice Handicap Index (VHI)].
    Wiskirska-Woźnica B, Wojnowski W.
    Przegl Lek; 2009 Nov; 66(10):565-6. PubMed ID: 20301881
    [Abstract] [Full Text] [Related]

  • 28. Relationship of botulinum dosage to duration of side effects and normal voice in adductor spasmodic dysphonia.
    Chang CY, Chabot P, Thomas JP.
    Otolaryngol Head Neck Surg; 2007 Jun; 136(6):894-9. PubMed ID: 17547976
    [Abstract] [Full Text] [Related]

  • 29. Correlation of the Voice Handicap Index (VHI) and the Voice-Related Quality of Life Measure (V-RQOL).
    Portone CR, Hapner ER, McGregor L, Otto K, Johns MM.
    J Voice; 2007 Nov; 21(6):723-7. PubMed ID: 16887328
    [Abstract] [Full Text] [Related]

  • 30. Botulinum toxin therapy for abductor spasmodic dysphonia.
    Woodson G, Hochstetler H, Murry T.
    J Voice; 2006 Mar; 20(1):137-43. PubMed ID: 16126369
    [Abstract] [Full Text] [Related]

  • 31. Botulinum toxin injection for adductor spastic dysphonia: patient self-ratings of voice and phonatory effort after three successive injections.
    Aronson AE, McCaffrey TV, Litchy WJ, Lipton RJ.
    Laryngoscope; 1993 Jun; 103(6):683-92. PubMed ID: 8502104
    [Abstract] [Full Text] [Related]

  • 32. Relationship of laryngeal botulinum toxin dosage to patient age, vitality, and socioeconomic issues.
    Young DL, Halstead LA.
    J Voice; 2014 Sep; 28(5):614-7. PubMed ID: 24954039
    [Abstract] [Full Text] [Related]

  • 33. A comparison of the efficacy of unilateral versus bilateral botulinum toxin injections in the treatment of adductor spasmodic dysphonia.
    Maloney AP, Morrison MD.
    J Otolaryngol; 1994 Jun; 23(3):160-4. PubMed ID: 8064952
    [Abstract] [Full Text] [Related]

  • 34. Prospective study of patients' subjective responses to botulinum toxin injection for spasmodic dysphonia.
    Liu TC, Irish JC, Adams SG, Durkin LC, Hunt EJ.
    J Otolaryngol; 1996 Apr; 25(2):66-74. PubMed ID: 8683655
    [Abstract] [Full Text] [Related]

  • 35. Vocal Parameters and Self-Perception in Individuals With Adductor Spasmodic Dysphonia.
    Rojas GVE, Ricz H, Tumas V, Rodrigues GR, Toscano P, Aguiar-Ricz L.
    J Voice; 2017 May; 31(3):391.e7-391.e18. PubMed ID: 27866691
    [Abstract] [Full Text] [Related]

  • 36. Development and validation of the voice handicap index-10.
    Rosen CA, Lee AS, Osborne J, Zullo T, Murry T.
    Laryngoscope; 2004 Sep; 114(9):1549-56. PubMed ID: 15475780
    [Abstract] [Full Text] [Related]

  • 37. Patient versus partner perception of voice handicap.
    Zraick RI, Risner BY, Smith-Olinde L, Gregg BA, Johnson FL, McWeeny EK.
    J Voice; 2007 Jul; 21(4):485-94. PubMed ID: 16950601
    [Abstract] [Full Text] [Related]

  • 38. Botox treatment in adductor spasmodic dysphonia: a meta-analysis.
    Boutsen F, Cannito MP, Taylor M, Bender B.
    J Speech Lang Hear Res; 2002 Jun; 45(3):469-81. PubMed ID: 12069000
    [Abstract] [Full Text] [Related]

  • 39. Long-term voice handicap index after type II thyroplasty using titanium bridges for adductor spasmodic dysphonia.
    Sanuki T, Yumoto E, Kodama N, Minoda R, Kumai Y.
    Auris Nasus Larynx; 2014 Jun; 41(3):285-9. PubMed ID: 24369905
    [Abstract] [Full Text] [Related]

  • 40. Effect of Botulinum Toxin and Surgery among Spasmodic Dysphonia Patients.
    van Esch BF, Wegner I, Stegeman I, Grolman W.
    Otolaryngol Head Neck Surg; 2017 Feb; 156(2):238-254. PubMed ID: 27803079
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.